2161.HKHKSE
JBM (Healthcare) Limited
HK$2.34
ListedFeb 5, 2021
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryHong Kong
Employees412
State-| CityKwun Tong| AddressUnit 808-811| Phone852 2267 2178
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and CCMG products. It is also involved in the manufactures, trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
8.9
?
Div. Rate
HK$0.20
?
Div. Yield
8.16%
?
Payout Ratio
63.98%
?
Max Consec. Div. Years
4 years
?
Longest Consec. Div.
4 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.94
?
Div. Growth Rate
100.00%
?
Score
72

Dividend History

Historical dividend payments by ex-dividend date.

Nov 28, 2025
HK$ 0.0975
Aug 11, 2025
HK$ 0.1150
Dec 17, 2024
HK$ 0.0550
Aug 15, 2024
HK$ 0.0405
Dec 7, 2023
HK$ 0.0345
Aug 15, 2023
HK$ 0.0250
Dec 8, 2022
HK$ 0.0050

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!